Patients with CV events had higher ANGPTL3 (P < 0.001), CRP (P < 0.001) levels, and severity of baseline CAD (P < 0.001) and lower statin use (P=0.022) than those without CV events. The gene discussed is ANGPTL3; the disease is coronary artery disorder.